The Principal Investigator of the proposed CTO is Dr. Mauro Ferrari, Chairman of Biomedical Engineering, Director of the Division of Nanomedicine, and Professor of Internal Medicine at UTHSC-H. Dr. Ferrari holds concurrent faculty appointments at MDACC, Rice U and UTA, and is the President of the Alliance for NanoHealth. He is trained in mathematics, mechanical engineering and medicine. He is a recognized leader in the development and application of biomedical nanotechnology. Co-leading the CTO is Senior Colnvestigator, Dr. Steven Curiey of MDACC, Professor and Chief, Gastrointestinal Tumor Surgery, Program Director, Gastrointestinal Tumor Multidisciplinary Care Center and the Charles B. Barker Chair in Surgery. He is a renowned Gl tumor surgeon and physician scientist. Drs. Ferrari and Curiey will lead the proposed CTO from the physical sciences and clinical and oncology sciences, respectively. Both have demonstrated experience to conduct and lead multidisciplinary research programs that bridge the physical sciences and biomedical and clinical sciences. CTO Center Administrative Unit, led by the PI and Senior Co-lnvestigator will be assisted by a Center Manager, Dr. Jason Sakamoto, to provide leadership and general administration for all activities related to this proposed CTO. Dr. Apostolia Tsimberidou, Assitant Professor at MDACC, will be Director of Clinical Translation, Education and Outreach. She will guide and advise the investigators in their research toward clinical translation. CTO Center Administrative Unit is responsible for: 1) providing administrative support to all projects and core resources of the CTO, 2) providing administrative support to develop and manage pilot project programs (Internal pilot projects-CAC, TransNetwork pilot projects-PSC, and external pilot projects-outreach), 3) convening CTO team meetings, CAC meetings, as well as scientific conferences and workshops, 4) supporting the participation of the CTO in PS-OC network and communicate with NCI staff, facilitate and prepare the CTO participation in NCI evaluation, 5) facilitating communication with other PS-OCs, and among other administrative and supportive functions, and 6) interfacing with other administrative resources and shared core facilities in the participating institutions.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-SRLB-9 (O1))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Methodist Hospital Research Institute
United States
Zip Code
Martinez, Jonathan O; Evangelopoulos, Michael; Bhavane, Rohan et al. (2015) Multistage Nanovectors Enhance the Delivery of Free and Encapsulated Drugs. Curr Drug Targets 16:1582-90
Corbo, Claudia; Parodi, Alessandro; Evangelopoulos, Michael et al. (2015) Proteomic Profiling of a Biomimetic Drug Delivery Platform. Curr Drug Targets 16:1540-7
Singh, Jaykrishna; Hussain, Fazle; Decuzzi, Paolo (2015) Role of differential adhesion in cell cluster evolution: from vasculogenesis to cancer metastasis. Comput Methods Biomech Biomed Engin 18:282-92
Wang, Zhihui; Butner, Joseph D; Kerketta, Romica et al. (2015) Simulating cancer growth with multiscale agent-based modeling. Semin Cancer Biol 30:70-8
Jaganathan, Hamsa; Mitra, Sucharita; Srinivasan, Srimeenakshi et al. (2014) Design and in vitro evaluation of layer by layer siRNA nanovectors targeting breast tumor initiating cells. PLoS One 9:e91986
Yang, Yong; Wolfram, Joy; Fang, Xiaohong et al. (2014) Polyarginine induces an antitumor immune response through binding to toll-like receptor 4. Small 10:1250-4
Koshkina, Nadezhda V; Briggs, Katrina; Palalon, Flavio et al. (2014) Autophagy and enhanced chemosensitivity in experimental pancreatic cancers induced by noninvasive radiofrequency field treatment. Cancer 120:480-91
Martinez, Jonathan O; Evangelopoulos, Michael; Karun, Vivek et al. (2014) The effect of multistage nanovector targeting of VEGFR2 positive tumor endothelia on cell adhesion and local payload accumulation. Biomaterials 35:9824-32
Gonzalez-Villasana, Vianey; Rodriguez-Aguayo, Cristian; Arumugam, Thiruvengadam et al. (2014) Bisphosphonates inhibit stellate cell activity and enhance antitumor effects of nanoparticle albumin-bound paclitaxel in pancreatic ductal adenocarcinoma. Mol Cancer Ther 13:2583-94
Koay, Eugene J; Truty, Mark J; Cristini, Vittorio et al. (2014) Transport properties of pancreatic cancer describe gemcitabine delivery and response. J Clin Invest 124:1525-36

Showing the most recent 10 out of 114 publications